Allogeneic hematopoietic stem cell transplantation (HSCT) is an important therapeutic
modality for patients with acute myelogenous leukemia (AML) with poor risk features …

Hematopoietic stem cell transplantation (HSCT) is a critical treatment modality for many
hematological and non-hematological diseases that is being extended to treat older …

Chimerism refers to the relative proportion of donor and recipient DNA after hematopoietic
stem cell transplantation (HSCT) and its quantitative follow-up is of great clinical utility in this …

Following hematopoietic cell transplantation (HCT), recipients are subjected to extensive
genetic testing to monitor the efficacy of the transplantation and identify relapsing malignant …

In recent years, advances in genetics and the integration of clinical-grade next-generation
sequencing (NGS) assays into patient care have facilitated broader recognition of hereditary …

Allogeneic hematopoietic cell transplantation (alloHCT) is a curative option for the treatment
of eligible patients with hematological malignancies. This modality confers a risk for life …

Dear Editor, Allogeneic hematopoietic cell transplantation (alloHCT) is an important and
curative therapeutic approach for patients with hematological malignancies. Given the …

Patients aged 50 or above diagnosed with myeloid neoplasms (MNs) are typically not
candidates for germline testing. However, approximately 8% carry pathogenic germline …

Allogeneic hematopoietic cell transplantation (allo-HCT) is an essential treatment option for
various neoplastic and non-neoplastic hematologic diseases. Although its efficacy is …

The recent study of Boettcher et al1 describes 5 cases of donor-engrafted clonal
hematopoiesis (CH), one of which progressed into myelodysplastic syndrome (MDS) in both …